The manufacturers can keep selling product until the FDA completes new reviews.Read More
Quarterly results benefited from market share gains and solid pricing, along with growth in the RRP segment.Read More
Strobykin aims to strengthen the firm’s commitment to smoke-free alternatives. Read More
The company achieved its highest quarterly EBITDA since the second quarter of 2021. Read More
Health Minister Hawari described the step as a milestone.Read More
Some 12 percent of cigarettes consumed are illicit, depriving governments of $40.5 billion in annual revenues. Read More
The company’s results were impacted by above-inflation tax hikes and weakening consumer purchasing power in Indonesia. Read More
This market echoes the beginning of the illicit vapor market, warns CEO Gifford.Read More
Stick sales make smoking affordable to vulnerable populations, say critics. Read More
The FDA will continue to share oversight with the Inter-Agency Committee on Tobacco. Read More
